Disclaimer: This Blog, its owner, creator & contributor is neither a research analyst nor an Investment Advisor and expressing opinion only as an Investor in Indian equities. He/She is not responsible for any loss arising out of any information, post or opinion appearing on this blog. Investors are advised to do own due diligence and/or consult financial consultant before acting on any such information.

Indian government is planning to ban almost 400 fixed dose combination medicines in another six months because of the dangerous side-effects as part of cleaning up the pharmaceutical sector issues addressed by Indian drug regulatory. Already the Indian ministry banned 344 fixed dose combination medicines which include some famous brands such as Vicks Action 500 Extra (P&G), Benadryl, and Phensedyl (Abott). As these medicines may cause anti-microbial resistance and it may even affect organs due to the high toxicity of those substances

Among world’s largest markets, India is one of the key market for fixed dose combination drugs which is almost 50% market share. As per the medical experts most of the medicines are irrational, they have not been approved by the Indian drug regulator.

It’s expected that the pharmaceutical companies may move to court which may invite a lengthy legal battle with Indian government to prove them that their medicines are perfect and the substances are within permissible limits. World’s pharma leader Pfizer has already received stay on the ban of its drug Corex. American pharmaceutical major Abott is also planning to move to court over its Phensedyl combination. It’s going to be a tuff time for pharmaceutical companies in Indian stock market.

I could remember a proverb “Prevention is better than cure” It’s better to be cautious and take care of your health

Hi All,
Hope you all are doing well. Due to unavoidable circumstances i couldn’t continue writing in my blog. Please apologize for the same. The same won’t happen again. Today i just started off writing posts on Indian stock market. Will continue posting on regular basis.

You can feel free to post your comments/feedback

Disclaimer: This Blog, its owner, creator & contributor is neither a research analyst nor an Investment Advisor and expressing opinion only as an Investor in Indian equities. He/She is not responsible for any loss arising out of any information, post or opinion appearing on this blog. Investors are advised to do own due diligence and/or consult financial consultant before acting on any such information. Author of this blog not providing any paid service and not sending bulk mails/SMS to anyone.